NCT07413146 2026-02-17
Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial
Sun Yat-sen University
Phase NA Not yet recruiting
Clinical Trials
11 trialsNCT06107920 2026-02-10
COnCERTO
University Hospital, Rouen
Phase 3 Recruiting
NCT01606098 2023-09-13
CAIRO4
Dutch Colorectal Cancer Group
Phase 3 Completed
NCT05468177 2022-07-21
CIFOXRC
Tongji Hospital
Phase 2 Unknown
NCT04889820 2021-09-22
Outcome of Neoadjuvant Chemotherapy for Obstructive Colon Cancer
The Catholic University of Korea
Phase NA Not yet recruiting
NCT00740961 2020-07-27
Older Patients With Newly Diagnosed Breast Cancer or Colon Cancer
Case Comprehensive Cancer Center
Terminated
NCT00408772 2017-06-09
Oxaliplatin, Capecitabine, and Bevacizumab Followed By Surgery and/or Radiofrequency Ablation in Patients With Colorectal Cancer
University of California, Davis
Phase 2 Withdrawn
NCT02882269 2016-08-30
Neoadjuvant Chemotherapy for the Treatment of Resectable Locally Advanced Colon Cancer
The First Affiliated Hospital with Nanjing Medical University
Phase 2/3 Unknown
NCT00262808 2013-10-16
GM-CSF and Combination Chemotherapy in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Colon Cancer
University of Rochester
Phase 2 Completed
NCT00005616 2013-06-19
Monoclonal Antibody Therapy in Treating Patients With Colorectal Cancer
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT00482222 2013-01-23
Combination Chemotherapy With or Without Cetuximab Before and After Surgery in Treating Patients With Resectable Liver Metastases Caused By Colorectal Cancer
University of Southampton
Phase 3 Unknown